Photo via Semafor

Trump administration backing off NIH grant order amid pushback

Read the original at Semafor ↗
Cite

Lim, D. (2026, September 23). Trump administration backing off NIH grant order amid pushback. Semafor. https://www.semafor.com/article/09/23/2026/trump-administration-backing-off-nih-grant-order-amid-pushback

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Semafor · collected 2026-09-23 · by David Lim

Quick Summary

The Trump administration is reconsidering its plan for an executive order that would increase presidential control over National Institutes of Health (NIH) grants following criticism and pressure from Senator Susan Collins and others. While the White House may still release a revised version of the order, it will likely take a different form than initially proposed after discussions revealed legal concerns and potential political ramifications. The original proposal, which sparked controversy during a meeting with NIH officials and OMB director Russell Vought, aimed to limit diversity initiatives within NIH funding decisions.
Written by AI on 2026-09-23, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The Trump administration is reconsidering its plan for an executive order that would give the president more control over National Institutes of Health (NIH) grant decisions, following pushback from lawmakers. The initial proposal aimed to limit diversity, equity, and inclusion efforts within NIH grants but faced criticism after a meeting involving NIH Director Jay Bhattacharya and OMB director Russell Vought, among others. Senate Appropriations Chair Susan Collins pressured the Office of Management and Budget to abandon the effort entirely, leading to changes in the proposed order's scope. While the White House may still release an executive order on NIH grants, it is likely to take a different approach than originally planned.

Written for “Trump Backing Off NIH Grant Order” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Trump Backing Off NIH Grant Order
Politics · 1 article(s) covering the same event.

Compared with similar articles

This article reads leans left and hedges 38% of its claims. Each row says how that neighbour differs.
Trump reportedly to form health funding board that could veto ‘woke’ initiatives Different event
The Guardian
Hedges 2 of 13 claims Outlet record 66/100
“Article A describes Trump's plan to form a health funding board, while Article B reports that the administration is backing off its initial plan amid pushback.”
Donald Trump seeks to bring health-research funding under his control, Politico reports Different event
The Hindu
⚖️ Leans right further right than this Hedges 0 of 7 claims Outlet record 60/100
“Article A describes Trump's initial directive to create an executive order for controlling NIH grants, while Article B reports on a change in approach by the administration following pushback from Senator Collins.”
Trump seeks to further tighten grip on biomedical research: US media Different event
The Straits Times
Hedges 2 of 11 claims Outlet record 66/100
“Article A describes Trump's intention to tighten control over biomedical research funding, while Article B reports that the administration is backing off its initial plan for an executive order on NIH grants due to pushback from Congress.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
13
sentences that state something as happening or true
Uncertain
38%
5 of 13 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
59/100
Semafor's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-23 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Semafor · 1432 article(s) · 3 correction(s) detected
Running correction rate · 3 correction(s)
2026-11-02
Tech earnings prompt ‘sober questions’
2026-11-02
AI trade falters after disappointing tech earnings
2026-10-16
LA's 'Selling Sunset' real estate agency opens a Dubai office

Who wrote this

David Lim
13 article(s) here · 1 carrying a prediction
🔮 The slowdown could happen in a number of ways, GOP aides working on health policy told me — depending on how big an election night Democrats have.
2026-10-29 · mixed framing · Republicans prep for slowdown of Trump’s healthcare agenda
🔮 But the food industry has raised concerns over what impact the forthcoming proposed definition could have on lawsuits across the country, and the White House is still scheduled to meet separately with several groups to discuss the issue in the coming weeks — including the National Restaurant Association on Tuesday, the Center for Food Safety on Thursday, and the Consumer Brands Association and Flavor and Extract Manufacturers Association in the days after the midterms.
2026-10-26 · mixed framing · Trump administration weighs ultra-processed food definition
🔮 Now the question is whether Kennedy could reconsolidate the same voters if he launches a new bid for the presidency.
2026-10-22 · assertive framing · The fight for MAHA's soul
🔮 A pending regulation under White House review could expand access to peptides, largely unregulated substances that are popular with wellness influencers and Health and Human Services Secretary Robert F. Kennedy Jr. In July, a panel of outside advisers to the Food and Drug Administration — which included individuals with connections to the peptide industry — narrowly recommended adding several peptides to the agency’s list of products that can be compounded, or mixed at pharmacies, despite concerns from FDA scientists.
2026-10-19 · speculative framing · Peptide group to meet with White House over pending regulatory plan
🔮 If Republicans ultimately support her, Overton will lead the agency responsible for vaccine policy after making a bigger contribution to the Trump administration’s effort to reverse decades of American policy on childhood vaccines than was widely understood.
2026-10-15 · assertive framing · Trump FDA nominee played key role in overhaul of childhood vaccine policy
🔮 With Sens. Roger Marshall, R-Kansas, and Susan Collins, R-Maine, fighting difficult reelection battles, it’s unclear who will replace Louisiana Sen. Bill Cassidy as the top Republican on the Senate HELP Committee.
2026-10-08 · mixed framing · Republican leadership of Senate health panel in doubt
🔮 When asked about his vote, Whitehouse pointed to a longstanding Rhode Island Medicare reimbursement policy issue he said he hopes Klomp will help resolve.
2026-09-25 · assertive framing · Klomp wins over Democrat in bid to be No. 2 HHS official
🔮 The Trump administration is backing off its initial plan for an executive order that would give the president greater influence over decisionmaking on National Institutes of Health grants, according to three people familiar with the process.
2026-09-23 · mixed framing · Trump administration backing off NIH grant order amid pushback
🔮 “You can imagine if here in the U.S., in Europe, we knew this Bundibugyo for 19 years, the vaccine would already be available,” Kaseya said.
2026-09-22 · assertive framing · Africa CDC director calls for local vaccine manufacturing
🔮 President Trump took a victory lap on his administration’s work on drug pricing today, announcing all 50 states will participate in the “most-favored-nation” program, saying “this one thing alone should win us the midterms.”
2026-09-18 · assertive framing · Health wonks question who saves in Trump drug program
Also by David Lim
Republicans prep for slowdown of Trump’s healthcare agenda
2026-10-29 · Semafor
Trump administration weighs ultra-processed food definition
2026-10-26 · Semafor
The fight for MAHA's soul
2026-10-22 · Semafor
Peptide group to meet with White House over pending regulatory plan
2026-10-19 · Semafor
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 13 articles by David Lim →

Topics

Congress NIH National Institutes of Health OMB the White House

Subjects

NIH ORG · 6× the White House ORG · 3× Congress ORG · 2× OMB ORG · 2× Appropriations ORG · 1× National Institutes of Health ORG · 1× Senate ORG · 1× Susan Collins PERSON · 1× The Scoop PERSON · 1× Trump PERSON · 1×

Narrative

The proposed order caused a furor after a Friday meeting where NIH Director Jay Bhattacharya and several administration officials, including OMB director Russell Vought, held a lengthy discussion about empowering the White House to involve itself in NIH grants in an effort to curtail diversity, equity, and inclusion efforts.
framing: mixed · carried by 1 article(s) · first seen 2026-09-23
🔮 The Trump administration is backing off its initial plan for an executive order that would give the president greater influence over decisionmaking on National Institutes of Health grants, according to three people familiar with the process.
2026-09-23 · Semafor
Trump administration backing off NIH grant order amid pushback · mixed framing

Claims (13 extracted, 5 hedged)

The Trump administration is backing off its initial plan for an executive order that would give the president greater influence over decisionmaking on National Institutes of Health grants, according to three people familiar with the process. uncertain
that → back → process
The move comes after Senate Appropriations Chair Susan Collins, R-Maine, pressured the Office of Management and Budget to abandon the effort outright. asserted
Collins → come → effort
While the White House is changing course on the planned order, it still may release one on NIH grants that takes a different tack. uncertain
that → change → tack
The White House and NIH declined to comment. asserted
House → decline → ?
The proposed order caused a furor after a Friday meeting where NIH Director Jay Bhattacharya and several administration officials, including OMB director Russell Vought, held a lengthy discussion about empowering the White House to involve itself in NIH grants in an effort to curtail diversity, equity, and inclusion efforts. asserted
Bhattacharya → propose → efforts
The meeting — which at times turned contentious — lasted more than an hour, according to a source familiar with it. uncertain
which → turn → it
It was first reported by The Washington Post. asserted
It → report → Post
The order has “since been pared back after White House officials further discussed and evaluated it,” a third person familiar with the process said. asserted
person → par → process
Even if the order moves forward, there are still outstanding legal questions about its scope and weight after Congress intervened to limit OMB influence over NIH spending in a government funding bill passed earlier this year. asserted
Congress → move → bill
“There is still a question of ‘Is it dead?’ versus ‘We don’t actually have a choice but to wait, so we might as well not do this before the midterms,’” said one pharmaceutical industry lobbyist. uncertain
lobbyist → be → midterms
If the administration had advanced the original scope of the planned NIH order, it could sink Congress’ ability to pass a stopgap spending bill at the end of the year. uncertain
it → advance → year
“They have to” pull back, a person familiar with the talks said. asserted
person → have → talks
“They won’t be able to pass a CR on December 11 if they issue an EO.” asserted
they → pass → EO
💬Give feedback
🕘History 🎫Support
Terms · Privacy · beta v2.0.0
Articles to 3 Nov 2026